<DOC>
	<DOCNO>NCT01050452</DOCNO>
	<brief_summary>This randomise , control , double-blinded clinical study investigate safety efficacy albendazole ( ALB ) , mebendazole ( MBD ) ivermectin ( IVM ) separately , ALB MBD combination IVM treatment Trichuris trichiura child age 5-14 year .</brief_summary>
	<brief_title>Safety Efficacy Drug Combinations Against Trichuris Trichiura</brief_title>
	<detailed_description />
	<mesh_term>Parasitic Diseases</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<mesh_term>Mebendazole</mesh_term>
	<mesh_term>Piperazine</mesh_term>
	<mesh_term>Piperazine citrate</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<criteria>Those enrolled class one six Are infect T. trichiura Whose parent consent willing participate Those acute chronic disease T. trichiura Those history serious adverse drug reaction</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>